Logo image of PAH3.DE

PORSCHE AUTOMOBIL HLDG-PRF (PAH3.DE) Stock Fundamental Analysis

FRA:PAH3 - DE000PAH0038

36.02 EUR
-0.23 (-0.63%)
Last: 9/10/2025, 5:36:15 PM
Fundamental Rating

4

PAH3 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 31 industry peers in the Automobiles industry. While PAH3 has a great health rating, there are worries on its profitability. PAH3 is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year PAH3 has reported negative net income.
In the past year PAH3 had a positive cash flow from operations.
PAH3 had positive earnings in 4 of the past 5 years.
PAH3 had a positive operating cash flow in each of the past 5 years.
PAH3.DE Yearly Net Income VS EBIT VS OCF VS FCFPAH3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B -20B

1.2 Ratios

The Return On Assets of PAH3 (-46.72%) is worse than 93.55% of its industry peers.
The Return On Equity of PAH3 (-57.02%) is worse than 77.42% of its industry peers.
With a decent Return On Invested Capital value of 5.62%, PAH3 is doing good in the industry, outperforming 77.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PAH3 is in line with the industry average of 6.57%.
Industry RankSector Rank
ROA -46.72%
ROE -57.02%
ROIC 5.62%
ROA(3y)-9.78%
ROA(5y)-2.27%
ROE(3y)-12.42%
ROE(5y)-3.83%
ROIC(3y)6.04%
ROIC(5y)6.18%
PAH3.DE Yearly ROA, ROE, ROICPAH3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

PAH3 has a Operating Margin of 99.24%. This is amongst the best in the industry. PAH3 outperforms 100.00% of its industry peers.
PAH3's Operating Margin has been stable in the last couple of years.
The Profit Margin and Gross Margin are not available for PAH3 so they could not be analyzed.
Industry RankSector Rank
OM 99.24%
PM (TTM) N/A
GM N/A
OM growth 3Y-0.12%
OM growth 5Y0.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAH3.DE Yearly Profit, Operating, Gross MarginsPAH3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PAH3 is destroying value.
The number of shares outstanding for PAH3 remains at a similar level compared to 1 year ago.
The number of shares outstanding for PAH3 remains at a similar level compared to 5 years ago.
Compared to 1 year ago, PAH3 has a worse debt to assets ratio.
PAH3.DE Yearly Shares OutstandingPAH3.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
PAH3.DE Yearly Total Debt VS Total AssetsPAH3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

PAH3 has an Altman-Z score of 1.81. This is not the best score and indicates that PAH3 is in the grey zone with still only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 1.81, PAH3 belongs to the best of the industry, outperforming 80.65% of the companies in the same industry.
The Debt to FCF ratio of PAH3 is 5.28, which is a neutral value as it means it would take PAH3, 5.28 years of fcf income to pay off all of its debts.
PAH3 has a better Debt to FCF ratio (5.28) than 74.19% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that PAH3 is not too dependend on debt financing.
The Debt to Equity ratio of PAH3 (0.21) is better than 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 5.28
Altman-Z 1.81
ROIC/WACC0.92
WACC6.09%
PAH3.DE Yearly LT Debt VS Equity VS FCFPAH3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B 40B 50B

2.3 Liquidity

PAH3 has a Current Ratio of 16.13. This indicates that PAH3 is financially healthy and has no problem in meeting its short term obligations.
PAH3 has a better Current ratio (16.13) than 100.00% of its industry peers.
A Quick Ratio of 16.13 indicates that PAH3 has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 16.13, PAH3 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 16.13
Quick Ratio 16.13
PAH3.DE Yearly Current Assets VS Current LiabilitesPAH3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

0

3. Growth

3.1 Past

The earnings per share for PAH3 have decreased strongly by -494.45% in the last year.
PAH3 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.13%.
The Revenue has been decreasing by -5.37% on average over the past years.
EPS 1Y (TTM)-494.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900.89%
Revenue 1Y (TTM)-34.13%
Revenue growth 3Y-9.48%
Revenue growth 5Y-5.37%
Sales Q2Q%-57.91%

3.2 Future

Based on estimates for the next years, PAH3 will show a small growth in Earnings Per Share. The EPS will grow by 7.33% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-37.59%
EPS Next 2Y-1.36%
EPS Next 3Y2.1%
EPS Next 5Y7.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PAH3.DE Yearly Revenue VS EstimatesPAH3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B
PAH3.DE Yearly EPS VS EstimatesPAH3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PAH3. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 4.33, which indicates a rather cheap valuation of PAH3.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PAH3 indicates a rather cheap valuation: PAH3 is cheaper than 90.32% of the companies listed in the same industry.
PAH3 is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.54, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.33
PAH3.DE Price Earnings VS Forward Price EarningsPAH3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

87.10% of the companies in the same industry are more expensive than PAH3, based on the Enterprise Value to EBITDA ratio.
100.00% of the companies in the same industry are more expensive than PAH3, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.85
EV/EBITDA 2.93
PAH3.DE Per share dataPAH3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150 200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.36%
EPS Next 3Y2.1%

More info and screens

6

5. Dividend

5.1 Amount

PAH3 has a Yearly Dividend Yield of 5.35%, which is a nice return.
PAH3's Dividend Yield is comparable with the industry average which is at 6.06.
PAH3's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 5.35%

5.2 History

The dividend of PAH3 has a limited annual growth rate of 2.98%.
Dividend Growth(5Y)2.98%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of PAH3 are negative and hence is the payout ratio. PAH3 will probably not be able to sustain this dividend level.
PAH3's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-3.91%
EPS Next 2Y-1.36%
EPS Next 3Y2.1%
PAH3.DE Yearly Income VS Free CF VS DividendPAH3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B -15B -20B

More info and screens

PORSCHE AUTOMOBIL HLDG-PRF

FRA:PAH3 (9/10/2025, 5:36:15 PM)

36.02

-0.23 (-0.63%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-13 2025-08-13
Earnings (Next)11-11 2025-11-11
Inst Owners12.96%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.52B
Analysts51
Price Target39.59 (9.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.35%
Yearly Dividend2.56
Dividend Growth(5Y)2.98%
DP-3.91%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.52%
PT rev (3m)-1.73%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-31.22%
EPS NY rev (3m)-31.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.33
P/S 1.61
P/FCF 3.85
P/OCF 3.85
P/B 0.16
P/tB 0.16
EV/EBITDA 2.93
EPS(TTM)-65.36
EYN/A
EPS(NY)8.33
Fwd EY23.12%
FCF(TTM)9.35
FCFY25.95%
OCF(TTM)9.35
OCFY25.95%
SpS22.41
BVpS229.28
TBVpS229.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.72%
ROE -57.02%
ROCE 7.98%
ROIC 5.62%
ROICexc 5.95%
ROICexgc 5.95%
OM 99.24%
PM (TTM) N/A
GM N/A
FCFM 41.71%
ROA(3y)-9.78%
ROA(5y)-2.27%
ROE(3y)-12.42%
ROE(5y)-3.83%
ROIC(3y)6.04%
ROIC(5y)6.18%
ROICexc(3y)6.21%
ROICexc(5y)6.32%
ROICexgc(3y)6.21%
ROICexgc(5y)6.33%
ROCE(3y)8.58%
ROCE(5y)8.78%
ROICexcg growth 3Y-8.5%
ROICexcg growth 5Y-7.91%
ROICexc growth 3Y-8.5%
ROICexc growth 5Y-7.78%
OM growth 3Y-0.12%
OM growth 5Y0.3%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 5.28
Debt/EBITDA 2.19
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.74
Cash Conversion 42.01%
Profit Quality N/A
Current Ratio 16.13
Quick Ratio 16.13
Altman-Z 1.81
F-Score3
WACC6.09%
ROIC/WACC0.92
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-494.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-900.89%
EPS Next Y-37.59%
EPS Next 2Y-1.36%
EPS Next 3Y2.1%
EPS Next 5Y7.33%
Revenue 1Y (TTM)-34.13%
Revenue growth 3Y-9.48%
Revenue growth 5Y-5.37%
Sales Q2Q%-57.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.28%
EBIT growth 3Y-9.59%
EBIT growth 5Y-5.09%
EBIT Next Year337.12%
EBIT Next 3Y25.48%
EBIT Next 5YN/A
FCF growth 1Y-23.64%
FCF growth 3Y25.04%
FCF growth 5Y14.85%
OCF growth 1Y-23.64%
OCF growth 3Y25.04%
OCF growth 5Y14.66%